PROGRAM

10.00 – 10.30
Doors open, registration & coffee

10.30 – 11.00
Welcome and introduction – The Trinational HealthTech Days story initiative

Speakers: Christian Elias Schneider, Managing director, Innovation Office University of Basel ; Bodo Brückner, Startup advisor coordinator, LSA Baden-Wuerttemberg ; Malaika Lauk, Senior Consultant health, BadenCampus ; Guillaume Vetter-Genoud, Director, Quest for health

11.00 – 11.30
Inspiration keynote #1 from Silicon Valley
Entrepreneurial mindset with Matt Goldman, General Partner, J2 Ventures

11.30 – 12.15
Panel discussion – Innovation-friendly… but startup-ready? Are corporates really backing early-stage healthtech innovation ?

Moderator: Alessandro Mazzetti, Innovation Office University of Basel
Speakers: Nathan Lawless, Head research external innovation Europe, CSL ; Andrea Lucarelli, Senior Innovation Manager, Roche ; Karl Mahler, former Head of Investor Relations, Roche ; Claire Barton, Director, Barton Oncology Ltd

12.15 – 13.30
Lunch and coffee break 

13.30 – 13.50
Inspiration keynote #2 from Silicon Valley
Entrepreneurial and knowledge journey with Jin Hyung Lee, Associate Professor of Neurology, Stanford

14.00 – 15.15

WORKSHOPS (Parallel sessions by sector)

BIOTECH – The untold learnings from setbacks in drug development

Moderator: Zaki Sellam, Executive chairman and president, Landmark BioVentures AG
Speakers: Markus Goebel, Director OSE Immunotherapeutics ; Daan Kok, Head of BD and strategy, Hemanext ; Seng Chin Mah, Chairman of the board, BioVersys AG

Synopsis: Drug development is often portrayed as a story of scientific progress and eventual success. Yet, behind every approved therapy lies a history of failures, delays, and hard-earned lessons. This panel will explore the hidden wisdom gained from setbacks across the drug development ecosystem—from biotech start-ups to CROs, big pharma, and venture capital.

By examining the challenges in human capital, clinical development, indication strategy, target product profiles (TPPs), and resource allocation, we aim to uncover the mistakes that shaped better decisions, the false starts that redirected strategy, and the enduring blind spots the industry still struggles with.

This candid and authentic discussion will reveal how organizations at different stages of the value chain perceive and respond to setbacks, and how these experiences can be turned into strategic advantages for the future of innovation.

MEDTECH – Medtech exploring innovations for enhanced patient journeys

Moderators: Bodo Brückner and Malaika Lauk
Speakers: Nina Lammers, Director Scientific Communication & Medical Education, Pfizer Pharma ; Matthias Warken, Global Co-Lead B. Braun ; Dennis Plachta, PhD, CTO and Co-founder neuroloop

Synopsis: The workshop “Medtech: Exploring innovations for enhanced patient journeys”, will provide exciting insights from leading industry experts and startups. Nina Lammers (Pfizer) will show how virtual worlds are changing business models, Matthias Warken (B. Braun) will talk about venture clienting and the digital future in clinics, and the startup neuroloop will present a groundbreaking implant for selective stimulation of the vagus nerve. Finally, the experts and founders will share their learnings and dos and don’ts when dealing with startups and corporations respectively.

We would like to encourage participants to engage in conversation with the speakers and with each other. Please prepare a short introduction (approx. 1 minute) describing your venture or company.

DIGITAL HEALTH – Reimagining drug development in the age of AI

Moderator: Celia Oculi, former Global Portfolio Strategy Lead, Roche
Speakers: Sanja Tomovska, CEO Quant Biomarkers ; Nicholas Kelley, Venture advisor, Alpha Intelligence Capital

Synopsis: How AI is transforming the drug development pipeline — from molecule identification and target validation to clinical trials, regulatory strategy, and go-to-market.

Themes to include: Speed and cost reduction, precision and personalization, data integration and real-world evidence, democratization of R&D tools, and inclusion of patient data and biomarkers.

15.15 – 15.30
Coffee break & transition to wrap-up session

15.30 – 15.45
Wrap up and closing

Key highlights and takeaways with Christian Elias Schneider, Managing Director, Innovation Office, University of Basel ; Bodo Brückner, Startup Advisor Coordinator, LSA Baden-Württemberg ; Malaika Lauk, Senior Consultant Health, BadenCampus ; Guillaume Vetter-Genoud, Director, Quest for health

15.45 – 17.45
Networking and apero